• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HSF1 和 p53 信号通路在癌症起始和进展中的相互作用:非致癌基因和致癌基因成瘾。

Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.

机构信息

Maria Skłodowska-Curie Institute - Oncology Center, Gliwice Branch, Wybrzeże Armii Krajowej 15, 44-101, Gliwice, Poland.

出版信息

Cell Oncol (Dordr). 2019 Oct;42(5):579-589. doi: 10.1007/s13402-019-00452-0. Epub 2019 Jun 10.

DOI:10.1007/s13402-019-00452-0
PMID:31183804
Abstract

BACKGROUND

The p53 and HSF1 transcription factors are key players in cellular responses to stress. They activate important signaling pathways triggering adaptive mechanisms that maintain cellular homeostasis. HSF1 is mainly activated by proteotoxic stress, and its induction leads to the synthesis of chaperones that provide proteome integrity. The p53 protein, which is primarily activated in response to DNA damage, causes cell cycle arrest allowing for DNA repair or directs cells to apoptosis, thereby maintaining genome integrity. Both signaling pathways are also involved in neoplastic transformation and tumor progression. Loss of tumor suppressor abilities of the wild-type p53 protein results in oncogenesis, whereas proper HSF1 action, though non-oncogenic itself, actively supports this process.

CONCLUSIONS

Here, we describe in detail the interplay between the p53 and HSF1 signaling pathways, with particular emphasis on the molecular mechanisms involved, as well as their importance for normal cellular behavior, cancer development, the effectiveness of anti-cancer therapies and their toxicity. Detailed knowledge of the complex interplay between HSF1 and p53 may form a basis for the design of new protocols for cancer treatment.

摘要

背景

p53 和 HSF1 转录因子是细胞应激反应的关键因素。它们激活重要的信号通路,触发适应性机制,维持细胞内稳态。HSF1 主要被蛋白毒性应激激活,其诱导导致伴侣蛋白的合成,提供蛋白质组的完整性。p53 蛋白主要在响应 DNA 损伤时被激活,导致细胞周期停滞,从而允许 DNA 修复或指导细胞凋亡,从而维持基因组的完整性。这两个信号通路也参与了肿瘤的转化和进展。野生型 p53 蛋白肿瘤抑制能力的丧失导致了癌变,而适当的 HSF1 作用本身虽然非致癌,但却积极地支持这一过程。

结论

在这里,我们详细描述了 p53 和 HSF1 信号通路之间的相互作用,特别强调了所涉及的分子机制,以及它们对正常细胞行为、癌症发展、抗癌治疗的效果及其毒性的重要性。详细了解 HSF1 和 p53 之间的复杂相互作用可能为设计新的癌症治疗方案奠定基础。

相似文献

1
Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction.HSF1 和 p53 信号通路在癌症起始和进展中的相互作用:非致癌基因和致癌基因成瘾。
Cell Oncol (Dordr). 2019 Oct;42(5):579-589. doi: 10.1007/s13402-019-00452-0. Epub 2019 Jun 10.
2
Nuclear stress bodies: Interaction of its components in oncogenic regulation.核应激体:其成分在致癌调控中的相互作用。
J Cell Biochem. 2019 Sep;120(9):14700-14710. doi: 10.1002/jcb.28731. Epub 2019 May 14.
3
Role of p53 in the Regulation of Cellular Senescence.p53 在细胞衰老调控中的作用。
Biomolecules. 2020 Mar 8;10(3):420. doi: 10.3390/biom10030420.
4
The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis.热休克蛋白,或 HSF1 介导的蛋白毒性应激反应在癌症中的作用:从蛋白质组稳定性到致癌作用。
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738). doi: 10.1098/rstb.2016.0525.
5
Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.野生型p53信号通路在抑制化学基因毒性剂诱导的细胞凋亡中的意义:对化疗结果的影响。
Int J Mol Sci. 2017 Apr 28;18(5):928. doi: 10.3390/ijms18050928.
6
IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis.IER5产生一种新型的低磷酸化活性形式的HSF1,并促进肿瘤发生。
Sci Rep. 2016 Jan 12;6:19174. doi: 10.1038/srep19174.
7
Acute HSF1 depletion induces cellular senescence through the MDM2-p53-p21 pathway in human diploid fibroblasts.急性 HSF1 耗竭通过 MDM2-p53-p21 通路诱导人二倍体成纤维细胞衰老。
J Cell Sci. 2018 May 8;131(9):jcs210724. doi: 10.1242/jcs.210724.
8
Genotoxic stress-mediated cell cycle activities for the decision of cellular fate.遗传毒性应激介导的细胞周期活动决定细胞命运。
Cell Cycle. 2011 Oct 1;10(19):3239-48. doi: 10.4161/cc.10.19.17460.
9
Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.在p53缺陷型自发肿瘤小鼠模型中,Hsf1功能丧失对淋巴瘤的选择性抑制作用
Oncogene. 2007 Aug 2;26(35):5086-97. doi: 10.1038/sj.onc.1210317. Epub 2007 Feb 19.
10
Heat-shock factor 1 both positively and negatively affects cellular clonogenic growth depending on p53 status.热休克因子 1 可根据 p53 状态,正向和负向地影响细胞集落形成生长。
Biochem J. 2013 Jun 1;452(2):321-9. doi: 10.1042/BJ20130098.

引用本文的文献

1
mutations drive therapy resistance via post-mitochondrial caspase blockade.突变通过线粒体后半胱天冬酶阻断导致治疗耐药。
bioRxiv. 2025 Aug 31:2025.08.28.672283. doi: 10.1101/2025.08.28.672283.
2
HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms.处于化疗耐药十字路口的热休克因子1:从细胞死亡机制的当前见解到未来展望
Front Cell Dev Biol. 2025 Jan 9;12:1500880. doi: 10.3389/fcell.2024.1500880. eCollection 2024.
3
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition.

本文引用的文献

1
Cooperative interaction among BMAL1, HSF1, and p53 protects mammalian cells from UV stress.BMAL1、HSF1和p53之间的协同相互作用可保护哺乳动物细胞免受紫外线应激。
Commun Biol. 2018 Nov 22;1:204. doi: 10.1038/s42003-018-0209-1. eCollection 2018.
2
Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.基质细胞和癌细胞之间的相互让步和妥协:推动肿瘤的发展和耐药性。
Cell Oncol (Dordr). 2018 Aug;41(4):353-367. doi: 10.1007/s13402-018-0388-2. Epub 2018 Jul 19.
3
Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target.
对抗PD-1定向免疫检查点抑制耐药的黑色素瘤患者的医疗需求和治疗选择
Cancers (Basel). 2023 Jun 30;15(13):3448. doi: 10.3390/cancers15133448.
4
p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment.癌症治疗中使用的化学放射治疗药物耐药背后的p53依赖性细胞保护机制
Cancers (Basel). 2023 Jun 28;15(13):3399. doi: 10.3390/cancers15133399.
5
Targeting HSF1 for cancer treatment: mechanisms and inhibitor development.靶向 HSF1 治疗癌症:机制与抑制剂开发。
Theranostics. 2023 Apr 17;13(7):2281-2300. doi: 10.7150/thno.82431. eCollection 2023.
6
Mitochondrial dynamics when mitochondrial toxic chemicals exposed in 3D cultured mouse embryonic stem cell.3D培养的小鼠胚胎干细胞暴露于线粒体毒性化学物质时的线粒体动力学
Toxicol Res. 2022 Dec 13;39(2):239-249. doi: 10.1007/s43188-022-00161-1. eCollection 2023 Apr.
7
The Emerging Role of Heat Shock Factor 1 (HSF1) and Heat Shock Proteins (HSPs) in Ferroptosis.热休克因子1(HSF1)和热休克蛋白(HSPs)在铁死亡中的新作用
Pathophysiology. 2023 Mar 14;30(1):63-82. doi: 10.3390/pathophysiology30010007.
8
Heat shock protein A2 is a novel extracellular vesicle-associated protein.热休克蛋白 A2 是一种新型细胞外囊泡相关蛋白。
Sci Rep. 2023 Mar 23;13(1):4734. doi: 10.1038/s41598-023-31962-5.
9
Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington's disease.肿瘤抑制因子 p53 调控亨廷顿病中的热休克因子 1 蛋白降解。
Cell Rep. 2023 Mar 28;42(3):112198. doi: 10.1016/j.celrep.2023.112198. Epub 2023 Mar 3.
10
Anchoring super-enhancer-driven oncogenic lncRNAs for anti-tumor therapy in hepatocellular carcinoma.锚定超级增强子驱动的致癌长链非编码 RNA 用于肝癌的抗肿瘤治疗。
Mol Ther. 2023 Jun 7;31(6):1756-1774. doi: 10.1016/j.ymthe.2022.11.013. Epub 2022 Dec 2.
功能获得性(GOF)突变型p53作为可操作的治疗靶点。
Cancers (Basel). 2018 Jun 7;10(6):188. doi: 10.3390/cancers10060188.
4
Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells.热休克因子 1 赋予 ERBB2 阳性乳腺癌细胞对拉帕替尼的耐药性。
Cell Death Dis. 2018 May 24;9(6):621. doi: 10.1038/s41419-018-0691-x.
5
Acute HSF1 depletion induces cellular senescence through the MDM2-p53-p21 pathway in human diploid fibroblasts.急性 HSF1 耗竭通过 MDM2-p53-p21 通路诱导人二倍体成纤维细胞衰老。
J Cell Sci. 2018 May 8;131(9):jcs210724. doi: 10.1242/jcs.210724.
6
Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death.非甾体抗炎药诱导的凋亡和自噬性细胞死亡使多药耐药癌细胞对热休克蛋白90抑制剂敏感。
Oncotarget. 2018 Jan 10;9(13):11303-11321. doi: 10.18632/oncotarget.24130. eCollection 2018 Feb 16.
7
Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action.分子伴侣监管基因组守护者:p53 肿瘤抑制因子作用的双重角色
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):161-174. doi: 10.1016/j.bbcan.2017.12.004. Epub 2018 Jan 31.
8
DNA damage responses and p53 in the aging process.衰老过程中的 DNA 损伤反应和 p53。
Blood. 2018 Feb 1;131(5):488-495. doi: 10.1182/blood-2017-07-746396. Epub 2017 Nov 15.
9
Mechanisms of transcriptional regulation by p53.p53 的转录调控机制。
Cell Death Differ. 2018 Jan;25(1):133-143. doi: 10.1038/cdd.2017.174. Epub 2017 Nov 10.
10
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.靶向热休克蛋白治疗癌症:一种有前途的治疗方法。
Int J Mol Sci. 2017 Sep 15;18(9):1978. doi: 10.3390/ijms18091978.